MED13L, mediator complex subunit 13L, 23389

N. diseases: 94; N. variants: 49
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Transposition of the Great Arteries, Dextro-Looped 1
0.700 GeneticVariation disease CLINVAR Dosage changes of MED13L further delineate its role in congenital heart defects and intellectual disability. 23403903 2013
Transposition of the Great Arteries, Dextro-Looped 1
0.700 Biomarker disease CTD_human
Transposition of the Great Arteries, Dextro-Looped 1
0.700 Biomarker disease GENOMICS_ENGLAND
Transposition of the Great Arteries, Dextro-Looped 1
0.700 GeneticVariation disease UNIPROT Missense mutations and gene interruption in PROSIT240, a novel TRAP240-like gene, in patients with congenital heart defect (transposition of the great arteries). 14638541 2003
Transposition of the Great Arteries, Dextro-Looped 1
0.700 CausalMutation disease CLINVAR De novo genic mutations among a Chinese autism spectrum disorder cohort. 27824329 2016
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS
0.700 GermlineCausalMutation disease ORPHANET Dosage changes of MED13L further delineate its role in congenital heart defects and intellectual disability. 23403903 2013
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS
0.700 Biomarker disease CTD_human
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS
0.700 CausalMutation disease CLINVAR Genotype-phenotype evaluation of MED13L defects in the light of a novel truncating and a recurrent missense mutation. 28645799 2017
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS
0.700 GermlineCausalMutation disease ORPHANET Novel de novo heterozygous loss-of-function variants in MED13L and further delineation of the MED13L haploinsufficiency syndrome. 25712080 2015
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS
0.700 Biomarker disease GENOMICS_ENGLAND Novel de novo heterozygous loss-of-function variants in MED13L and further delineation of the MED13L haploinsufficiency syndrome. 25712080 2015
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS
0.700 GeneticVariation disease CLINVAR Genotype-phenotype evaluation of MED13L defects in the light of a novel truncating and a recurrent missense mutation. 28645799 2017
CUI: C0008925
Disease: Cleft Palate
Cleft Palate
0.300 Biomarker disease GENOMICS_ENGLAND Novel de novo heterozygous loss-of-function variants in MED13L and further delineation of the MED13L haploinsufficiency syndrome. 25712080 2015
CUI: C0020796
Disease: Profound Mental Retardation
Profound Mental Retardation
0.300 Biomarker disease CTD_human Deep sequencing reveals 50 novel genes for recessive cognitive disorders. 21937992 2011
CUI: C0917816
Disease: Mental deficiency
Mental deficiency
0.300 Biomarker disease CTD_human Deep sequencing reveals 50 novel genes for recessive cognitive disorders. 21937992 2011
CUI: C0040761
Disease: Transposition of Great Vessels
Transposition of Great Vessels
0.160 GeneticVariation disease BEFREE Subsequent mutational screening of 97 patients with isolated dextro-looped TGA revealed 3 missense mutations in PROSIT240, which were not detected in 400 control chromosomes. 14638541 2003
CUI: C0040761
Disease: Transposition of Great Vessels
Transposition of Great Vessels
0.160 Biomarker disease BEFREE A decade after the designation of MED13L as a gene and its link to intellectual disability (ID) and dextro-looped transposition of great arteries in 2003, we previously described a recognizable syndrome due to MED13L haploinsufficiency. 28645799 2017
CUI: C0040761
Disease: Transposition of Great Vessels
Transposition of Great Vessels
0.160 GeneticVariation disease BEFREE Novel increasing evidence showed that missense mutations in MED13L gene are associated with transposition of great arteries while MED12, MED13, MED15, and MED30, have been correlated with heart development. 31255603 2019
CUI: C0040761
Disease: Transposition of Great Vessels
Transposition of Great Vessels
0.160 GeneticVariation disease BEFREE Missense mutations in MED13L are linked to transposition of the great arteries and non-syndromal intellectual disability. 24781760 2015
CUI: C0040761
Disease: Transposition of Great Vessels
Transposition of Great Vessels
0.160 GeneticVariation disease BEFREE A chromosomal balanced translocation disrupting the MED13L (Mediator complex subunit13-like) gene, encoding a subunit of the Mediator complex, was previously associated with transposition of the great arteries (TGA) and intellectual disability (ID), and led to the identification of missense mutations in three patients with isolated TGA. 23403903 2013
CUI: C0040761
Disease: Transposition of Great Vessels
Transposition of Great Vessels
0.160 GeneticVariation disease BEFREE Heterozygous MED13L variants cause transposition of the great arteries and intellectual disability (ID). 25758992 2015
CUI: C0040761
Disease: Transposition of Great Vessels
Transposition of Great Vessels
0.160 Biomarker disease HPO
CUI: C0026351
Disease: Moderate intellectual disability
Moderate intellectual disability
0.120 CausalMutation disease CLINVAR
CUI: C0026351
Disease: Moderate intellectual disability
Moderate intellectual disability
0.120 Biomarker disease HPO
CUI: C0026351
Disease: Moderate intellectual disability
Moderate intellectual disability
0.120 Biomarker disease BEFREE MED13L-related intellectual disability is characterized by moderate intellectual disability (ID), speech impairment, and dysmorphic facial features. 29959045 2019
CUI: C0026351
Disease: Moderate intellectual disability
Moderate intellectual disability
0.120 Biomarker disease BEFREE MED13L haploinsufficiency syndrome has been described in two patients and is characterized by moderate intellectual disability (ID), conotruncal heart defects, facial abnormalities and hypotonia. 24781760 2015